Loading
Latest filing published 17 Feb 2009 for REGEN BIOLOGICS INC, €3,887.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
William Rodkey discloses dealings in Regen Biologics Inc to SEC (Form 4). We count 4 filings; the first trade dates from 30 November 2006 and the latest from 13 February 2009.
Every open-market trade on record is a purchase: 4 purchases worth €14k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2009, the count stands at 1 purchase and no sales.
A typical purchase (the median) is worth €3,475.
The newest entry dates from 17 February 2009: an open-market purchase of €3,887, in Regen Biologics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations